Codexis (CDXS) Operating Leases (2019 - 2026)
Codexis (CDXS) recorded quarterly Operating Leases of $32.4 million in Q1 2026, up 7.5% quarter-over-quarter from $30.2 million in Q4 2025, and up 18.33% on a YoY basis from $27.4 million in Q1 2025.
Codexis (CDXS) Operating Leases (2019 - 2026) Analysis & Trends
Codexis' Operating Leases history runs 8 years deep, the most recent figure standing at $32.4 million for Q1 2026.
- In Q1 2026, Operating Leases rose 18.33% year-over-year to $32.4 million; the TTM figure through Mar 2026 stood at $32.4 million (up 18.33% YoY), while the FY2025 annual figure was $30.2 million, up 7.09% from the prior year.
- Operating Leases was $32.4 million for Q1 2026 at Codexis, up from $30.2 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $47.3 million in Q1 2022 to a low of $9.1 million in Q3 2024.
- Historically, Operating Leases has averaged $28.9 million across 5 years, with a median of $28.2 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Operating Leases tumbled 71.19% in 2024, then surged 182.47% in 2025.
- A 5-year view of Operating Leases shows it stood at $43.6 million in 2022, then tumbled by 63.28% to $16.0 million in 2023, then soared by 75.76% to $28.2 million in 2024, then increased by 7.09% to $30.2 million in 2025, then grew by 7.5% to $32.4 million in 2026.
- The last three Operating Leases figures came in at $32.4 million (Q1 2026), $30.2 million (Q4 2025), and $25.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.42 Mn |
| Dec 31, 2025 | 30.16 Mn |
| Sep 30, 2025 | 25.80 Mn |
| Jun 30, 2025 | 26.61 Mn |
| Mar 31, 2025 | 27.40 Mn |
| Dec 31, 2024 | 28.16 Mn |
| Sep 30, 2024 | 9.13 Mn |
| Jun 30, 2024 | 10.19 Mn |
| Mar 31, 2024 | 11.23 Mn |
| Dec 31, 2023 | 16.02 Mn |
| Sep 30, 2023 | 19.98 Mn |
| Jun 30, 2023 | 35.38 Mn |
| Mar 31, 2023 | 36.85 Mn |
| Dec 31, 2022 | 43.64 Mn |
| Sep 30, 2022 | 44.89 Mn |
| Jun 30, 2022 | 46.11 Mn |
| Mar 31, 2022 | 47.28 Mn |
| Dec 31, 2021 | 43.56 Mn |
| Sep 30, 2021 | 23.00 Mn |
| Jun 30, 2021 | 23.66 Mn |